A Pilot Study to Investigate Pharmacokinetic Characteristics After Co-administration of HCP0910 and HGP1011
Latest Information Update: 12 Jan 2017
Price :
$35 *
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary) ; Tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacokinetics
- 01 Jun 2016 Status changed from not yet recruiting to completed.
- 16 May 2015 New trial record